Salivary Progesterone as a Biomarker in Pregnancy
Meulenberg Eline P*
ELTI Support VOF, Ambachtsweg 5, 6581 AX Malden, The Netherlands
- *Corresponding Author:
- Meulenberg Eline P
ELTI Support VOF, Ambachtsweg
5, 6581 AX Malden, The Netherlands
Tel: +31 24 358 7662
E-mail: [email protected]
Received Date: May 30, 2015; Accepted Date: June 23, 2015; Published Date: June 25, 2015
Citation: Meulenberg EP (2015) Salivary Progesterone as a Biomarker in Pregnancy. Biochem Anal Biochem 4:188. doi:10.4172/2161-1009.1000188
Copyright: © 2015 Meulenberg EP. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Progesterone was measured in the saliva of pregnant women at the end of gestation. Samples were collected two times daily (morning and afternoon) during the last two week before the expected delivery date and 2 days after delivery. Analysis was performed using commercial ELISA kits after simple freezing, thawing and centrifugation of the samples. It appeared that during the period before delivery the level of progesterone was in a steady state, until about 2 days before delivery, at which point a rapid decrease could be detected. Immediately after delivery, levels decreased again to nonpregnant values. For comparison reasons, two different ELISA kits were used and evaluated for suitability. In addition, in a preliminary experiment, the applicability and usefulness of the additional determination of salivary estriol was investigated. In conclusion, salivary progesterone may be used as indicator for imminent delivery in pregnant women. Salivary estriol may be an additional parameter that supports the usefulness of salivary progesterone. Further, estriol is said to be a trigger to delivery and is also known to give information about the wellbeing of the fetus. Consequently, its analysis may further contribute to predict the time of delivery, to optionally take measures in the case of premature delivery or complicated pregnancies and give information about the health of the fetus. The results of this study are only intended to indicate the possibility to develop a biosensor for home-use that would greatly contribute to the health of mother and newborn.